The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rapid organoid development, drug screening, and neoadjuvant chemotherapy response prediction for patients with locally advanced bladder cancer.
 
Samuel D. Kaffenberger
Consulting or Advisory Role - clovis oncology; MDxHealth
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jason Brown
No Relationships to Disclose
 
Nathan Merrill
No Relationships to Disclose
 
Kathryn Marchetti
No Relationships to Disclose
 
Li Wei Bao
No Relationships to Disclose
 
Xu Cheng
No Relationships to Disclose
 
Aaron M. Udager
No Relationships to Disclose
 
Lindsey A. Herrel
No Relationships to Disclose
 
Nathalie Vandecan
No Relationships to Disclose
 
Jeffrey S. Montgomery
Consulting or Advisory Role - Ferring
 
Khaled Hafez
No Relationships to Disclose
 
Alon Weizer
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - Myriad Genetics; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
 
Matthew Soellner
No Relationships to Disclose
 
Sofia Merajver
No Relationships to Disclose